XNAS · KALA
+3.23% · +$0.0449 · Vol 97.5K
Market closed · last close 4:00 PM ET · price as of 19:50:14 ET
KALA BIO, Inc. Common Stock

KALA BIO, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.43
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is KALA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for KALA are being assembled.
About KALA BIO, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2017
Employees
6
Country
US

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.41
Day high
$1.41
Day low
$1.30
Previous close
$1.39
52W high
$3.61
-60.25% from high
52W low
$1.30
6% of range
Market cap
$25.8M
EPS
$-4.3300
Shares out
18.6M
Volume
97.5K
VWAP
$1.36
Price history computed in-house
1W
-25.65%
1M
-40.95%
SMA 50 $2.41 · below
SMA 200 $2.41 · below
52W position 6%
Veridion warehouse edge

Warehouse intelligence for KALA.

Veridion Score
60
0: 871: 572: 133: 904: 295: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

KALA insider activity

KALA BIO, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for KALA.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

KALA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KALA in this window.
Lobbying spend

KALA lobbying filings, year to date.

Registered lobbying filings matched to KALA BIO, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KALA in this window.
Latest news · KALA
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for KALA.
Options
Sovereign unlock shows live options positioning for KALA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.